U
Biofrontera AG BFAGY
OTC PK
Recommendation
--
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
D
Sell 11/9/2021Upgraded
Biofrontera AG (BFAGY) was upgraded to D from E+ on 11/09/2021.
E
Sell 11/8/2021Downgrade
Biofrontera AG (BFRA) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index.
D
Sell 8/5/2021Upgraded
Biofrontera AG (BFRA) was upgraded to D from D- on 8/5/2021 due to a large increase in the solvency index and valuation index. Debt to equity declined from 2.79 to 0.96, and the quick ratio increased from 2.52 to 3.54.
D
Sell 8/28/2020Downgrade
Biofrontera AG (BFRA) was downgraded to D- from D on 8/28/2020 due to a decline in the growth index and volatility index.
D
Sell 8/5/2020Upgraded
Biofrontera AG (BFRA) was upgraded to D from D- on 8/5/2020 due to a noticeable increase in the volatility index and total return index.
D
Sell 5/22/2020Downgrade
Biofrontera AG (BFRA) was downgraded to D- from D on 5/22/2020 due to a major decline in the growth index, solvency index and volatility index. Debt to equity increased from 2.02 to 5.44, EBIT declined 99.03% from -$2.53M to -$5.04M, and earnings per share declined from -$0.1038 to -$0.1544.
D
Sell 5/12/2020Upgraded
Biofrontera AG (BFRA) was upgraded to D from D- on 5/12/2020 due to an increase in the volatility index and total return index.
D
Sell 4/27/2020Downgrade
Biofrontera AG (BFRA) was downgraded to D- from D on 4/27/2020 due to a major decline in the efficiency index, total return index and volatility index. Total capital declined 6.38% from $39.89M to $37.34M.
D
Sell 10/21/2019Downgrade
Biofrontera AG (BFRA) was downgraded to D from D+ on 10/21/2019 due to a large decline in the volatility index and total return index.
D
Sell 9/3/2019Upgraded
Biofrontera AG (BFRA) was upgraded to D+ from D on 9/3/2019 due to a substantial increase in the efficiency index, total return index and volatility index. Net income increased 536.56% from -$3M to $13.08M, and total capital increased 39.99% from $38.89M to $54.44M.
D
Sell 5/1/2019Upgraded
Biofrontera AG (BFRA) was upgraded to D from D- on 5/1/2019 due to a large increase in the volatility index, total return index and efficiency index. Net income increased 172.54% from -$5.32M to $3.86M, and total capital increased 12.23% from $30.59M to $34.33M.
D
Sell 4/3/2019Upgraded
Biofrontera AG (BFRA) was upgraded to D- from E+ on 4/3/2019 due to an increase in the volatility index and total return index.
E
Sell 3/12/2019Downgrade
Biofrontera AG (BFRA) was downgraded to E+ from D- on 3/12/2019 due to a decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.78 to 1.03, and the quick ratio declined from 7.87 to 5.37.
D
Sell 11/1/2018Upgraded
Biofrontera AG (BFRA) was upgraded to D- from E on 11/1/2018 due to an increase in the volatility index, solvency index and growth index.
E
Sell 8/1/2018Upgraded
Biofrontera AG (BFRA) was upgraded to E from E- on 8/1/2018 due to a large increase in the solvency index, valuation index and efficiency index. The quick ratio increased from 3.07 to 8.77, total capital increased 123.81% from $19.1M to $42.75M, and debt to equity declined from 3.63 to 0.59.
E
Sell 5/29/2018Downgrade
Biofrontera AG (BFRA) was downgraded to E- from E on 5/29/2018 due to a noticeable decline in the volatility index.
E
Sell 5/11/2018Upgraded
Biofrontera AG (BFRA) was upgraded to E from E- on 5/11/2018 due to an increase in the volatility index.
E
Sell 5/10/2018None
Biofrontera AG (BFAGY) was downgraded to E- from U on 05/10/2018.
Weiss Ratings